195 related articles for article (PubMed ID: 21771713)
1. Scleromyxedema vs scleredema: a diagnostic challenge.
Conde Fernandes I; Sanches M; Velho G; Lobo I; Alves R; Selores M
Eur J Dermatol; 2011; 21(5):822-3. PubMed ID: 21771713
[No Abstract] [Full Text] [Related]
2. [Monoclonal immunoglobulin (M-Ig) and skin diseases from the group of mucinoses--scleredema adultorum Buschke and scleromyxedema. Description of four cases and an overview of therapies].
Adam Z; Szturz P; Krejčí M; Vašků V; Pour L; Michalková E; Ševčíková S; Čermáková Z; Veselý K; Vaníček J; Pourová E; Král Z; Mayer J
Vnitr Lek; 2015 Dec; 61(12):1072-87. PubMed ID: 26806503
[TBL] [Abstract][Full Text] [Related]
3. European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis.
Knobler R; Moinzadeh P; Hunzelmann N; Kreuter A; Cozzio A; Mouthon L; Cutolo M; Rongioletti F; Denton CP; Rudnicka L; Frasin LA; Smith V; Gabrielli A; Aberer E; Bagot M; Bali G; Bouaziz J; Braae Olesen A; Foeldvari I; Frances C; Jalili A; Just U; Kähäri V; Kárpáti S; Kofoed K; Krasowska D; Olszewska M; Orteu C; Panelius J; Parodi A; Petit A; Quaglino P; Ranki A; Sanchez Schmidt JM; Seneschal J; Skrok A; Sticherling M; Sunderkötter C; Taieb A; Tanew A; Wolf P; Worm M; Wutte NJ; Krieg T
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1581-1594. PubMed ID: 28786499
[TBL] [Abstract][Full Text] [Related]
4. Combination of intravenous immunoglobulins and lenalidomide in the treatment of scleromyxedema.
Brunet-Possenti F; Hermine O; Marinho E; Crickx B; Descamps V
J Am Acad Dermatol; 2013 Aug; 69(2):319-20. PubMed ID: 23866873
[No Abstract] [Full Text] [Related]
5. Scleromyxedema.
Bogner RR; Wetter DA; Dingli D
Intern Med; 2014; 53(21):2561-2. PubMed ID: 25366027
[No Abstract] [Full Text] [Related]
6. Scleroderma mimics.
Nashel J; Steen V
Curr Rheumatol Rep; 2012 Feb; 14(1):39-46. PubMed ID: 22131103
[TBL] [Abstract][Full Text] [Related]
7. [Marked improvement in scleromyxedema with high-dose intravenous immunoglobulin].
Topf S; Simon M; Schell H; Lüftl M
Hautarzt; 2007 Jun; 58(6):525-8. PubMed ID: 17165069
[TBL] [Abstract][Full Text] [Related]
8. Case for diagnosis: l. Scleredma adultorum 2. ?Scleromyxedema 3. ?Dermatomyositis.
Berke M
Arch Dermatol; 1969 Oct; 100(4):512-4. PubMed ID: 5358131
[No Abstract] [Full Text] [Related]
9. Buschke's scleredema and concomitant diseases: report of five cases and literature review.
Lipozencić J; Marasović D; Barisić-Drusko V
Acta Dermatovenerol Croat; 2005; 13(3):147-52. PubMed ID: 16146615
[TBL] [Abstract][Full Text] [Related]
10. Scleromyxedema with an interstitial granulomatous-like pattern: a rare histologic variant mimicking granuloma annulare.
Rongioletti F; Cozzani E; Parodi A
J Cutan Pathol; 2010 Oct; 37(10):1084-7. PubMed ID: 19638067
[TBL] [Abstract][Full Text] [Related]
11. Scleromyxoedema: clinical follow-up after successful treatment with high-dose immunoglobulins reveals different long-term outcomes.
Bidier M; Zschoche C; Gholam P; Enk AH; Hadaschik EN
Acta Derm Venereol; 2012 Jul; 92(4):408-9. PubMed ID: 22278389
[No Abstract] [Full Text] [Related]
12. Scleromyxedema: a multicenter study of characteristics, comorbidities, course, and therapy in 30 patients.
Rongioletti F; Merlo G; Cinotti E; Fausti V; Cozzani E; Cribier B; Metze D; Calonje E; Kanitakis J; Kempf W; Stefanato CM; Marinho E; Parodi A
J Am Acad Dermatol; 2013 Jul; 69(1):66-72. PubMed ID: 23453242
[TBL] [Abstract][Full Text] [Related]
13. Suspected cardiac toxicity to intravenous immunoglobulin used for treatment of scleromyxedema.
Binitha MP; Nandakumar G; Thomas D
Indian J Dermatol Venereol Leprol; 2008; 74(3):248-50. PubMed ID: 18583794
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of intravenous immunoglobulin in Arndt-Gottron scleromyxedema].
Lopez L; Wierzbicka-Hainaut E; Villers A; Guillet G
Ann Dermatol Venereol; 2009 Apr; 136(4):330-6. PubMed ID: 19361699
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of poststreptococcal scleredema adultorum Buschke with intravenous immunoglobulins.
Aichelburg MC; Loewe R; Schicher N; Sator PG; Karlhofer FM; Stingl G; Jalili A
Arch Dermatol; 2012 Oct; 148(10):1126-8. PubMed ID: 23069949
[No Abstract] [Full Text] [Related]
16. Scleredema Vs. scleroderma. Differentiation of often confused disorders is explained.
Kelly AP; Schiff BL
R I Med J; 1973 Jun; 56(6):235-6. PubMed ID: 4515769
[No Abstract] [Full Text] [Related]
17. [Mucinosis papulosa--scleromyxedema].
Jakubowicz K; Langner A
Przegl Dermatol; 1966; 53(2):159-66. PubMed ID: 4223593
[No Abstract] [Full Text] [Related]
18. Localized cutaneous fibrosing disorders.
Yaqub A; Chung L; Rieger KE; Fiorentino DF
Rheum Dis Clin North Am; 2013 May; 39(2):347-64. PubMed ID: 23597968
[TBL] [Abstract][Full Text] [Related]
19. Uncommon Presentation of Scleromyxoedema with a Distribution Pattern Mimicking a Photodermatosis.
Kirchberger MC; Sticherling M; Erdmann M
Acta Derm Venereol; 2017 Aug; 97(8):979-980. PubMed ID: 28421236
[No Abstract] [Full Text] [Related]
20. [Diagnosis and differential diagnosis of Buschke's scleredema adultorum].
Dietel K
Kinderarztl Prax; 1969 Oct; 37(10):448-55. PubMed ID: 5366553
[No Abstract] [Full Text] [Related]
[Next] [New Search]
